Copenhagen: The use of the Oxford cod vaccine has been suspended for another three weeks in Denmark, and investigations are underway into allegations of thickening and clotting of the vaccine.

According to the international website, the use of the AstraZeneca vaccine has been suspended for another three weeks due to further investigations into unusual cases of blood clots and possible clots in Denmark.

Denmark was among the first European countries to stop using the vaccine this month over fears of a blood clot related to AstraZeneca.

Most of the countries that had temporarily imposed sanctions on AstraZeneca have now resumed use of the vaccine following recommendations from the European Union’s Drug Watch and the World Health Organization (WHO).

But Danish officials say they cannot rule out a link between the vaccine and the highly rare disease in two local cases. They are also reviewing other cases reported in Europe.

“Our final decision on the further use of the Code 19 vaccine, AstraZeneca, is uncertain,” Soren Brostrom, director of the Danish Health Authority, told a news briefing.

“There has been a lot of research in this regard, but we have not yet reached a conclusion, so we have decided to extend the suspension of vaccine use,” he said.

If the re-use of AstraZeneca is not approved after 3 weeks, the vaccination process in Denmark will be delayed by 4 weeks.

It may be recalled that before stopping the use of AstraZeneca in Denmark, about one and a half million people had been vaccinated against this disease, in Denmark 500,000 people have been vaccinated with Pfizer / Biotech vaccine and 37 thousand people have been vaccinated against Moderna.

Last week, the European Medicines Agency and the World Health Organization declared AstraZeneca safe.